Diflumidone

CAS : 22736-85-2

Ref. 3D-XAA73685

Informations sur le produit

• Nom: Diflumidone
• Synonymes: Diflumidone [INN:BAN], 3'-Benzoyl-1,1-difluoro-methanesulfonanilide, Brn 2151784, Diflumidona, Diflumidona [INN-Spanish], Diflumidonum, Diflumidonum [INN-Latin], N-(3-Benzoylphenyl)-1,1-difluoromethanesulfonamide, R 807, R 807 (Pharmaceutical), Unii-E96467495S, Methanesulfonamide, N-(3-benzoylphenyl)-1,1-difluoro- (9CI), Methanesulfonanilide, 3'-benzoyl-1,1-difluoro-

Description

Diflumidone is a nonsteroidal anti-inflammatory drug that has been shown to be effective in the treatment of diabetic patients. Diflumidone inhibits prostaglandin synthesis by irreversible inhibition of cyclooxygenase, leading to decreased inflammation and pain. Diflumidone belongs to the class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It is used for the relief of symptoms such as pain, stiffness and swelling in various conditions such as arthritis, gouty arthritis, osteoarthritis, and rheumatoid arthritis. Diflumidone has been shown to have pharmacokinetic properties that are similar between rats and humans. It is rapidly absorbed from the gastrointestinal tract with a bioavailability exceeding 80%. The drug is eliminated primarily through renal excretion with an elimination half-life of approximately 4 hours.

Diflumidone is a nonsteroidal anti-inflammatory drug that has been

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 311.31 g/mol
• Formule: C₁₄H₁₁F₂NO₃S
• Degré de pureté: Min. 95%